MC3 Cardiopulmonary

MC3 Cardiopulmonary (formerly MC3, Inc.) is a medical device company specializing in the development of innovative cardiopulmonary support technologies, particularly extracorporeal membrane oxygenation (ECMO) systems. The company focuses on addressing acute and chronic clinical needs for patients with respiratory and cardiac failure. Following its acquisition by Medtronic in 2024, it remains dedicated to creating life-restoring medical devices that improve patient outcomes in critical care settings.